Author:
Miller Colton M.,Xu Yongmei,Kudrna Katrina M.,Hass Blake E.,Kellar Brianna M.,Egger Andrew W.,Liu Jian,Harris Edward N.
Funder
National Institutes of Health
Reference46 articles.
1. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety;Hirsh;Chest,2001
2. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence;Hull;Thromb. Haemost.,2013
3. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis;Shen;Am. J. Kidney Dis.,2012
4. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism;Robertson;Cochrane Database Syst. Rev.,2017
5. Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis;Ikesaka;Thromb. Res.,2014
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献